Literature DB >> 18682459

Illnesses at high altitude.

Robert B Schoene1.   

Abstract

High-altitude illnesses have profound consequences on the health of many unsuspecting and otherwise healthy individuals who sojourn to high altitude for recreation and work. The clinical manifestations of high-altitude illnesses are secondary to the extravasation of fluid from the intravascular to extravascular space, especially in the brain and lungs. The most common of these illnesses, which can present as low as 2,000 m, is acute mountain sickness, which is usually self-limited but can progress to the more severe and potentially fatal entities of high-altitude cerebral edema and high-altitude pulmonary edema. This article will briefly review normal adaptation to high altitude and then more extensive reviews of the clinical presentations, prevention, and treatments of these potentially fatal conditions. Research on the mechanisms of these conditions will also be reviewed. A better understanding of these disorders by practitioners will lead to improved prevention and rational treatment for the increasing number of people visiting high-altitude areas around the globe. There will not be space for writing about high-altitude residents, medical conditions in low-altitude residents going to high altitude, or training for athletes at high altitude. These topics deserve another article.

Entities:  

Mesh:

Year:  2008        PMID: 18682459     DOI: 10.1378/chest.07-0561

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  33 in total

1.  [Acetazolamide in high altitude trips].

Authors:  Francisco Javier García Nicolás
Journal:  Aten Primaria       Date:  2010-05-18       Impact factor: 1.137

2.  Hypoxia: good guy or bad guy?

Authors:  Martin Burtscher; Nikolaus C Netzer
Journal:  Sleep Breath       Date:  2010-09       Impact factor: 2.816

Review 3.  Is high altitude pulmonary edema relevant to Hawai'i?

Authors:  Seth Lewis Cornell
Journal:  Hawaii J Med Public Health       Date:  2014-11

4.  Changes in mitochondrial enzymatic activities of monocytes during prolonged hypobaric hypoxia and influence of antioxidants: A randomized controlled study.

Authors:  Tobias M Merz; Jacqueline Pichler Hefti; Urs Hefti; Andreas Huber; Stephan M Jakob; Jukka Takala; Siamak Djafarzadeh
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

Review 5.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

6.  [Exercise and the detection of severe acute mountain sickness].

Authors:  Adrian Garófoli; Paula Montoya; Carlos Elías; Roberto Benzo
Journal:  Medicina (B Aires)       Date:  2010       Impact factor: 0.653

7.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

8.  Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m).

Authors:  Barbara E Jones; Suzy Stokes; Suzi McKenzie; Eric Nilles; Gregory J Stoddard
Journal:  Wilderness Environ Med       Date:  2012-10-10       Impact factor: 1.518

9.  High-altitude medicine.

Authors:  Swapnil J Paralikar; Jagdish H Paralikar
Journal:  Indian J Occup Environ Med       Date:  2010-01

10.  VEGFA SNPs and transcriptional factor binding sites associated with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Authors:  Norman E Buroker; Xue-Han Ning; Zhao-Nian Zhou; Kui Li; Wei-Jun Cen; Xiu-Feng Wu; Wei-Zhong Zhu; C Ronald Scott; Shi-Han Chen
Journal:  J Physiol Sci       Date:  2013-04-04       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.